BLINATUMOMAB
Clinical trials for BLINATUMOMAB explained in plain language.
Never miss a new study
Get alerted when new BLINATUMOMAB trials appear
Sign up with your email to follow new studies for BLINATUMOMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare leukemia: drug combo enters first human tests
Disease control Not yet recruitingThis early-stage trial tests whether combining two drugs, blinatumomab and revumenib, is safe for people with a rare form of acute lymphoblastic leukemia (ALL) caused by a KMT2A gene change. The study will enroll 20 adults, including those whose cancer has returned or not respond…
Matched conditions: BLINATUMOMAB
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:28 UTC
-
Under-the-skin shot aims to keep leukemia from coming back
Disease control Not yet recruitingThis study tests whether giving blinatumomab as a shot under the skin can control small amounts of leftover leukemia (called measurable residual disease) in adults with B-cell acute lymphoblastic leukemia. About 40 participants will receive the drug to see if it is safe and can p…
Matched conditions: BLINATUMOMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
New combo shot and pill aims to tame tough leukemia
Disease control Not yet recruitingThis study tests whether giving two drugs together—blinatumomab as a shot under the skin and olverembatinib as a pill—can help control a fast-growing blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). About 60 adults with newly diagnosed or r…
Matched conditions: BLINATUMOMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC